Trade AstraZeneca ^AZN

AstraZeneca's $5bn drug promise is no 'buy' signal for Deutsche

Amgen (NASDAQ:AMGN) Shares Gap Down - What's Next? - Stock Observer

Could AstraZeneca (AZN)'s Stronger Growth Make it a Better Bet than Amgen (AMGN)?

AstraZeneca Falls 1.3% Despite a 34% COPD Breakthrough

Amgen's Imdelltra Sales Surge 115% as Lung-Cancer Combination Meets Major Goals

Manufacturing Stocks Worth Watching - September 9th - Stock Observer

Cidel Asset Management Inc. Takes Position in Astrazeneca Plc $AZN

Stock Analysts' Updated EPS Estimates for September 9th (AZN, BBOT, BBOX, BEAM, BRZE, CASY, COA, CRE, DNLM, DYN) - Daily Political

AstraZeneca (LON:AZN) Earns "Buy" Rating from Jefferies Financial Group - Markets Daily

AstraZeneca (LON:AZN) Earns Outperform Rating from Royal Bank Of Canada - Daily Political

Amgen and AstraZeneca Reveal Promising Lung Cancer Drug Combination That Enhances Survival Rates, ETPharma

AstraZeneca PLC (LON:AZN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - Daily Political

RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial

AstraZeneca Falls Today Even as Imfinzi Wins a Landmark Survival Test

FDA clears Astrazeneca's Etcamah for first-line breast cancer

Amgen And AstraZeneca's IMDELLTRA-Imfinzi Combo Shows Survival Benefit In Phase 3 ES-SCLC Study

AstraZeneca Reports Positive Data For Tozorakimab From Phase III OBERON, TITANIA Trials In COPD

Correction to AstraZeneca Article | Morningstar

AstraZeneca Says Lung-Disease Drug Shows Benefits Across Patient Groups | Morningstar

AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes

Top Manufacturing Stocks To Watch Today - September 8th - Daily Political

IMFINZI® plus tarlatamab demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer | INN

AstraZeneca's Etcamah Approved In U.S. For 1st-Line Advanced HR-Positive Breast Cancer

Astrazeneca Plc $AZN Shares Sold by HighTower Advisors LLC

Commercial Assessment of the Diabetic Nephropathy Market 2026-2036 Featuring Boehringer Ingelheim, Eli Lilly, Bayer, AstraZeneca, UCB Biopharma, Serodus, and Palatin

Astrazeneca Plc $AZN Shares Bought by Allianz Asset Management GmbH

Dilated Cardiomyopathy Clinical Trial Pipeline Gains Momentum: 8+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight | ABNewswire

AstraZeneca India Launches Rs 25 Lakh Cancer Cover for Employees, ETHRWorld

J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)

Astrazeneca Plc $AZN Shares Sold by Groupe la Francaise

Amundi Purchases 1,036,635 Shares of Astrazeneca Plc $AZN

AstraZeneca Announces Approval Of Etcamah Combination In The US

Citi Keeps Their Buy Rating on AstraZeneca (AZN)

FDA Approves Guardant360 CDx Companion Diagnostic For ESR1-Mutated Breast Cancer

AstraZeneca's (AZN) Buy Rating Reiterated at Berenberg Bank - Stock Observer

Best Manufacturing Stocks To Follow Today - September 5th

Haleon And 2 British AI Healthcare Stocks To Watch

US FDA approves AstraZeneca's new breast cancer pill Etcamah: Dosage, high risk and side effects - All you need to know

3 British AI Stocks With Revenue Growth Up To 14%

AstraZeneca's breast cancer pill gets approval from the FDA

FDA Approves AstraZeneca Treatment for Advanced Breast Cancer - Update | Morningstar

AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca's ETCAMAH™ (camizestrant) in Advanced Breast Cancer

Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes

C4X Discovery to receive milestone payment for NRF2 exclusive worldwide license agreement | Valuespectrum.com

Robbins Farley Buys New Shares in Astrazeneca Plc $AZN - Markets Daily

Sigma Planning Corp Cuts Holdings in Astrazeneca Plc $AZN - Zolmax

I asked ChatGPT what will be the first trillion-pound UK stock. It said…

Robbins Farley Purchases New Shares in Astrazeneca Plc $AZN - Stock Observer

Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program

Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma

Top Stock Reports for AMD, Costco & AstraZeneca

Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?

Deutsche Bank Aktiengesellschaft Reaffirms Sell Rating for AstraZeneca (LON:AZN) - Markets Daily

Rehmann Capital Advisory Group Grows Stake in Astrazeneca Plc $AZN - Zolmax

Astrazeneca Plc $AZN Shares Bought by Rehmann Capital Advisory Group - Markets Daily

Current therapeutic landscape and future treatment perspectives of MASH

Molecular mechanisms and pathogenesis of MASH

What Does AstraZeneca (LSE:AZN) News Mean For Its Cancer And Pipeline Growth?

Taiwan's Best Companies to Work for in Asia Transformed a Talent Crisis into a Strategic Advantage

What Does AstraZeneca (LSE:AZN) Gain From Its Latest Oncology Advances?

AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer

What Is IDEAYA Biosciences (IDYA) Setting Up With Its IDE849 Phase 3 Path?

Quantitative Investment Management LLC Boosts Stake in Astrazeneca Plc $AZN

AstraZeneca And Daiichi Sankyo Gain EU Nod For Enhertu Plus Pertuzumab In HER2+ Breast Cancer

Astrazeneca Plc $AZN Shares Purchased by Quantitative Investment Management LLC - Stock Observer

Astrazeneca synthesizes new KRAS mutant inhibitors | BioWorld

AstraZeneca Loses Suit Seeking Block on Colorado Pharmacy Law

From Padcev to PF-08634404: Pfizer's Oncology Growth Push

Reviewing AstraZeneca (AZNCF) and Its Competitors - Zolmax

Reviewing AstraZeneca (AZNCF) & The Competition - Markets Daily

Astrazeneca FY2026 EPS Forecast Lowered by Erste Group Bank

Top Manufacturing Stocks To Keep An Eye On - August 30th - Stock Observer

Astrazeneca Plc $AZN Shares Sold by Davidson Investment Advisors

Thornburg Investment Management Inc. Acquires 32,775 Shares of Astrazeneca Plc $AZN - Daily Political

Davidson Investment Advisors Trims Position in Astrazeneca Plc $AZN - Daily Political

Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors

Top Manufacturing Stocks To Research - August 28th - Zolmax

Head-To-Head Analysis: AstraZeneca (AZNCF) versus Its Rivals - Stock Observer

Tezspire Crossing to EoE? Astrazeneca, Amgen say phase III a win

BioCryst is profitable. Now it wants to buy more rare disease drugs

Genentech doubles down on ADC-resistance via $1B DualityBio pact

AstraZeneca (LSE:AZN) Reports Positive TEZSPIRE Phase 3 Results, Is The Discount Too Wide?

AstraZeneca Stock Remains 14% Lower Despite Tezspire Phase 3 Success

Glencore and GSK mine euros for popular deals

AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study

AstraZeneca, Amgen's Tezspire Meets Co-Primary, Key Secondary Endpoints In Phase 3 EoE Trial

AstraZeneca drug succeeds in trial for swallowing disorder

Ageing, Innovation and AI: 10 Healthcare Stocks Positioned to Benefit | Financial Horse

AstraZeneca Vietnam upgrades logistics system to support growing operations

Analysts Set Astrazeneca Plc (NYSE:AZN) PT at $211.00 - Zolmax

AstraZeneca lands its largest ever euro deal

AstraZeneca prices €2.55bn euro bond sale across four tranches

Here Are Monday's Top Wall Street Analyst Research Calls: AstraZeneca, Celestica, Chipotle Mexican Grill, Domino's Pizza, Fortune Brands, Golar LNG, Jersey Mike's Subs, Roku, and More

Towards a global collaborative approach to living guideline development in rheumatology